Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 51

1.

uPAR-targeted optical imaging contrasts as theranostic agents for tumor margin detection.

Yang L, Sajja HK, Cao Z, Qian W, Bender L, Marcus AI, Lipowska M, Wood WC, Wang YA.

Theranostics. 2013 Dec 17;4(1):106-18. doi: 10.7150/thno.7409. eCollection 2013.

PMID:
24396518
[PubMed - in process]
Free PMC Article
2.

Nd3+ sensitized up/down converting dual-mode nanomaterials for efficient in-vitro and in-vivo bioimaging excited at 800 nm.

Li X, Wang R, Zhang F, Zhou L, Shen D, Yao C, Zhao D.

Sci Rep. 2013 Dec 18;3:3536. doi: 10.1038/srep03536.

PMID:
24346622
[PubMed - in process]
Free PMC Article
3.

Fluorescence molecular tomography: principles and potential for pharmaceutical research.

Stuker F, Ripoll J, Rudin M.

Pharmaceutics. 2011 Apr 26;3(2):229-74. doi: 10.3390/pharmaceutics3020229.

PMID:
24310495
[PubMed]
Free PMC Article
4.

Whole cell-SELEX aptamers for highly specific fluorescence molecular imaging of carcinomas in vivo.

Shi H, Cui W, He X, Guo Q, Wang K, Ye X, Tang J.

PLoS One. 2013 Aug 12;8(8):e70476. doi: 10.1371/journal.pone.0070476. eCollection 2013.

PMID:
23950940
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Optical tecnology developments in biomedicine: history, current and future.

Nioka S, Chen Y.

Transl Med UniSa. 2011 Oct 17;1:51-150. Print 2011 Sep.

PMID:
23905030
[PubMed]
Free PMC Article
6.

Quantitative imaging of single upconversion nanoparticles in biological tissue.

Nadort A, Sreenivasan VK, Song Z, Grebenik EA, Nechaev AV, Semchishen VA, Panchenko VY, Zvyagin AV.

PLoS One. 2013 May 14;8(5):e63292. doi: 10.1371/journal.pone.0063292. Print 2013.

PMID:
23691012
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Molecular imaging probes for diagnosis and therapy evaluation of breast cancer.

Meng Q, Li Z.

Int J Biomed Imaging. 2013;2013:230487. doi: 10.1155/2013/230487. Epub 2013 Feb 26.

PMID:
23533377
[PubMed]
Free PMC Article
8.

Photoremovable protecting groups in chemistry and biology: reaction mechanisms and efficacy.

Klán P, Šolomek T, Bochet CG, Blanc A, Givens R, Rubina M, Popik V, Kostikov A, Wirz J.

Chem Rev. 2013 Jan 9;113(1):119-91. doi: 10.1021/cr300177k. Epub 2012 Dec 21. Review. No abstract available.

PMID:
23256727
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Multifunctional in vivo vascular imaging using near-infrared II fluorescence.

Hong G, Lee JC, Robinson JT, Raaz U, Xie L, Huang NF, Cooke JP, Dai H.

Nat Med. 2012 Dec;18(12):1841-6. doi: 10.1038/nm.2995. Epub 2012 Nov 18.

PMID:
23160236
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Molecular imaging probe development: a chemistry perspective.

Nolting DD, Nickels ML, Guo N, Pham W.

Am J Nucl Med Mol Imaging. 2012 Jul 10;2(3):273-306.

PMID:
22943038
[PubMed]
Free PMC Article
11.

Molecular plasmonics for biology and nanomedicine.

Zheng YB, Kiraly B, Weiss PS, Huang TJ.

Nanomedicine (Lond). 2012 May;7(5):751-70. doi: 10.2217/nnm.12.30. Review.

PMID:
22630155
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Exogenous Molecular Probes for Targeted Imaging in Cancer: Focus on Multi-modal Imaging.

Joshi BP, Wang TD.

Cancers (Basel). 2010 Jun 11;2(2):1251-87. doi: 10.3390/cancers2021251.

PMID:
22180839
[PubMed]
Free PMC Article
13.

Using in-vivo fluorescence imaging in personalized cancer diagnostics and therapy, an image and treat paradigm.

Ardeshirpour Y, Chernomordik V, Capala J, Hassan M, Zielinsky R, Griffiths G, Achilefu S, Smith P, Gandjbakhche A.

Technol Cancer Res Treat. 2011 Dec;10(6):549-60. Review.

PMID:
22066595
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Confocal endomicroscopy: instrumentation and medical applications.

Jabbour JM, Saldua MA, Bixler JN, Maitland KC.

Ann Biomed Eng. 2012 Feb;40(2):378-97. doi: 10.1007/s10439-011-0426-y. Epub 2011 Oct 13. Review.

PMID:
21994069
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

High vascular delivery of EGF, but low receptor binding rate is observed in AsPC-1 tumors as compared to normal pancreas.

Samkoe KS, Sexton K, Tichauer KM, Hextrum SK, Pardesi O, Davis SC, O'Hara JA, Hoopes PJ, Hasan T, Pogue BW.

Mol Imaging Biol. 2012 Aug;14(4):472-9. doi: 10.1007/s11307-011-0503-5.

PMID:
21847690
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Characterization of chemical, radiochemical and optical properties of a dual-labeled MMP-9 targeting peptide.

Azhdarinia A, Wilganowski N, Robinson H, Ghosh P, Kwon S, Lazard ZW, Davis AR, Olmsted-Davis E, Sevick-Muraca EM.

Bioorg Med Chem. 2011 Jun 15;19(12):3769-76. doi: 10.1016/j.bmc.2011.04.054. Epub 2011 May 6.

PMID:
21612930
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

BRCAA1 monoclonal antibody conjugated fluorescent magnetic nanoparticles for in vivo targeted magnetofluorescent imaging of gastric cancer.

Wang K, Ruan J, Qian Q, Song H, Bao C, Zhang X, Kong Y, Zhang C, Hu G, Ni J, Cui D.

J Nanobiotechnology. 2011 May 25;9:23. doi: 10.1186/1477-3155-9-23.

PMID:
21612621
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Activatable aptamer probe for contrast-enhanced in vivo cancer imaging based on cell membrane protein-triggered conformation alteration.

Shi H, He X, Wang K, Wu X, Ye X, Guo Q, Tan W, Qing Z, Yang X, Zhou B.

Proc Natl Acad Sci U S A. 2011 Mar 8;108(10):3900-5. doi: 10.1073/pnas.1016197108. Epub 2011 Feb 22.

PMID:
21368158
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Current and future clinical applications for optical imaging of cancer: from intraoperative surgical guidance to cancer screening.

Hadjipanayis CG, Jiang H, Roberts DW, Yang L.

Semin Oncol. 2011 Feb;38(1):109-18. doi: 10.1053/j.seminoncol.2010.11.008.

PMID:
21362519
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Molecular imaging of HER2-positive breast cancer: a step toward an individualized 'image and treat' strategy.

Capala J, Bouchelouche K.

Curr Opin Oncol. 2010 Nov;22(6):559-66. doi: 10.1097/CCO.0b013e32833f8c3a. Review.

PMID:
20842031
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk